Inflammatory Breast Cancer
Melissa Conrad Stöppler, MD
Melissa Conrad Stöppler, MD, is a U.S. board-certified Anatomic Pathologist with subspecialty training in the fields of Experimental and Molecular Pathology. Dr. Stöppler's educational background includes a BA with Highest Distinction from the University of Virginia and an MD from the University of North Carolina. She completed residency training in Anatomic Pathology at Georgetown University followed by subspecialty fellowship training in molecular diagnostics and experimental pathology.
Jerry R. Balentine, DO, FACEP
Dr. Balentine received his undergraduate degree from McDaniel College in Westminster, Maryland. He attended medical school at the Philadelphia College of Osteopathic Medicine graduating in1983. He completed his internship at St. Joseph's Hospital in Philadelphia and his Emergency Medicine residency at Lincoln Medical and Mental Health Center in the Bronx, where he served as chief resident.
- Inflammatory breast cancer facts
- What is inflammatory breast cancer?
- How is inflammatory breast cancer different from other breast cancers?
- What are the signs and symptoms of inflammatory breast cancer?
- How do health-care professionals diagnose inflammatory breast cancer?
- What are the stages of inflammatory breast cancer?
- What is the treatment for inflammatory breast cancer?
- What are the survival rates and prognosis for inflammatory breast cancer?
- Find a local Oncologist in your town
Inflammatory breast cancer facts
- Inflammatory breast cancer is breast cancer that has spread to the lymphatic system, causing symptoms of inflammation (redness, swelling, tenderness) in the breast.
- Symptoms of inflammatory breast cancer include
- skin changes,
- dimpling of the skin,
- possibly, a lump or mass in the breast.
- As with other types of breast cancer, a tissue biopsy is done to confirm the diagnosis of breast cancer.
- Inflammatory breast cancers are stage III or stage IV at the time of diagnosis.
- Treatment of inflammatory breast cancers is multimodal and involves surgery, chemotherapy, and radiation therapy.
- Inflammatory breast cancer is more aggressive and tends to have a worse prognosis than other types of breast cancer.
- Targeted therapies such as trastuzumab (Herceptin) or hormonal therapies may also be given, depending upon whether or not the tumor cells express hormone receptors or the HER2 protein.
- Survival rates for inflammatory breast cancer are not as favorable as those for other types of breast cancer.
What is inflammatory breast cancer?
Inflammatory breast cancer is a rare form of breast cancer. It is typically a very aggressive disease and is called "inflammatory" because the cancer cells block the lymphatic vessels, resulting in changes in the breast (swelling and redness) that make the breast appear to be inflamed. Over 230,000 women in the United States are diagnosed with breast cancer each year; inflammatory breast cancers make up only 1%-5% of breast cancers.
Find support and advances in treatment.